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A number of intervention strategies to improve the rate of early stage breast cancer 
detection have been proposed and evaluated.  Though good effectiveness data exist, 
policymakers and medical administrators may be reluctant to implement such interventions 
because of cost considerations.  Few cost-effectiveness analyses have been conducted on 
culturally-sensitive interventions that increase mammography screening rates or reduce barriers 
to receiving timely diagnostic testing and treatment for African-American women. This paper 
discusses an innovative cost effectiveness model, funded by the National Cancer Institute, and 
presents microeconomic estimates the cost of twelve community-based intervention strategies 
designed to improve early stage breast cancer detection rates and appropriate follow-up after an 
abnormal mammogram among African-American women.  An innovation in the estimates is to 
include the value of women’s time.   
 
Community-based program costs range from $47 to $161 per patient on an ongoing basis. 
Same day scheduling of a mammogram with or without patient transportation, public service 
announcements, physician education, physician audit with feedback, and same day scheduling of 
a biopsy cost $47-$53 per patient per year on an ongoing basis. Interventions that require full-
time personnel to maintain the program, such as patient reminder letters, theory-based education, 
physician reminders, and telephone counseling, are more expensive and cost approximately $54-
$57 per patient on an ongoing basis.  The three most expensive interventions are the mobile 
mammography van, lay health workers, and church based navigators, costing approximately $67-
$161 per patient 
 
In conclusion, the added costs of community-based cancer control programs for 
vulnerable African-American women are small and have the potential to be offset by the gains in 
quality-adjusted life years saved as a result of detection at an earlier stage of diagnosis and 
improved follow-up and treatment, particularly among high-risk communities. 
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“We offer many life saving procedures in medicine and yet our society’s priorities make them 
unavailable.  Our discoveries permit longer and longer lives and yet, our quality of life is out of 
balance.  How we solve these problems in our country, and even in our world, will depend on 
how humane we are in the application of scientific technologies and how scientifically informed 
we are in making social policy decisions.” 
 




 In the United States, approximately 182,000 women develop breast cancer and 46,000 die 
from it each year.1  Breast cancer is the second most frequent oncologic diagnosis in women.1  
Though the incidence of breast cancer has increased 55% between 1950 and the present, the 
mortality rate over that period has declined, perhaps in part because cancers are detected at an 
earlier stage.2-4  However, the racial gap in breast cancer mortality is widening.  In particular, 
breast cancer mortality rates have declined for white women since 1990 but not for African-
American women.5, 6  In 1980, breast cancer mortality was similar in African-American and 
white women.  However, by 1990 it was 16% higher among African-American women than 
among white women and 29% higher in 1995.5  Although breast cancer mortality rates have 
remained relatively stable for African-American women, they have not experienced the same 
rate of decline as white women, thus, leading to the widening of this mortality disparity.5 
 
 Much of the difference in mortality rates between women of differing socioeconomic 
status or race may be attributable to access to and utilization of preventive services.  Routine 
screening with mammography and clinical breast examination has been shown to decrease 
mortality rates from breast cancer by 20-30 percent.7-9  Yet African-American women are 2-5 
times more likely to have a late stage diagnosis10, 11 and prior to diagnosis are 2-4 times less 
likely to have received preventive mammography or clinical breast exams than white women.12-
13
   
 
 A number of intervention strategies to improve the rate of early stage breast cancer 
detection have been proposed and evaluated.14-39  Though good effectiveness data exist for many 
interventions, policymakers and medical administrators may be reluctant to implement such 
interventions because few cost-effectiveness analyses have been conducted on interventions that 
increase mammography screening rates or reduce barriers to receiving timely diagnostic testing.  
The purpose of this paper is to discuss an innovative cost effectiveness model under 
development, funded by the National Cancer Institute, and to present preliminary data on the cost 
of twelve intervention strategies with the potential to improve early stage breast cancer detection 
rates and improved follow-up after an abnormal mammogram among African-American women. 
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Overview of Cost Effectiveness Models 
 
Cost effectiveness analysis (CEA) has become the leading quantitative tool of the health 
policy sciences for aiding in the process of making decisions and setting priorities for preventive 
medical care delivery strategies.40  However, many of the factors that crucially affect the results 
of cost effectiveness analyses vary by age, race, and socio-economic status.  Blanket policy 
statements based on the results of CEA for general populations can result in prevention policies 
that overlook the particular circumstances of  vulnerable subgroups of the population.  For 
instance, most cost effectiveness analyses of recommended protocols for breast cancer screening 
and treatment assume appropriate utilization.  However, without culturally-sensitive follow-up 
and outreach programs in place for both providers and patients, vulnerable African American 
women will likely under-utilize appropriate services.  While many CEAs of breast cancer control 
have been developed for general populations, there are no models to date of cost effective breast 
cancer control strategies designed for African American women.41-47   
 
 With these considerations in mind, we are undertaking an innovative cost effectiveness 
analysis of breast cancer control strategies among African American women, that includes an 
analysis of twelve different provider-targeted and patient-targeted effective interventions to 
increase appropriate utilization.   
 
 Twelve Interventions 
 
The twelve interventions selected for this study are based largely on the work of Mandelblatt48 
and Yabroff49, supplemented by suggestions from community health experts in breast cancer 
prevention who are members of our National Advisory Committee.  In general, the interventions 
were chosen to represent categories established by Mandelblatt48 and Yabroff49, where  
interventions are grouped as patient-targeted or provider-targeted and within these groups are 
categorized as inreach (reminder letters, same-day screening, theory-based education, physician 
reminders, audit with feedback, physician education, telephone counseling, same-day biopsy) or 
outreach (lay health worker, church-based navigator, mobile mammography van, public service 
announcements) strategies.  Eight of the twelve interventions have been proven effective using 
data from controlled trials.  However, to our knowledge, studies of effectiveness are not 
available for same-day biopsy, lay health worker, church-based navigator, and mobile 
mammography van.  The twelve intervention strategies that will be discussed in this paper are 
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TABLE 1-Twelve Interventions to Improve Breast Cancer 
Detection, Diagnosis, and Treatment 
 
Interventions to Increase 
Mammography Use 
Interventions to Improve Follow-up 
After Abnormal Mammogram 
Patient-Targeted               Provider-Targeted Patient-Targeted               Provider-Targeted 
Reminder Letters                    Physician Reminders 
Same-day Screening               Audit with Feedback 
Theory-based Education         Physician Education 
Lay Health Worker Navigator 
Church-based Navigator 
Mobile Mammography Van 






Interventions to Increase Mammography Use 
 
 Patient-targeted intervention strategies.  Patient-targeted intervention strategies to 
increase mammography use include sending reminder letters to patients of the need for a 
mammogram,14-19 scheduling of a mammogram on the same day it is ordered by a physician,20 
theory-based education delivered by telephone counseling,37 peer recruitment and outreach 
strategies21-24 using lay health workers and church-based navigators, operating a mobile 
mammography unit,25, 26 and conducting public communications campaigns.27 
 
 Under the reminder letter scenario we examined the costs associated with sending a 
patient a pre-scheduled appointment reminder letter.  For same day scheduling of a 
mammogram, we estimated the costs associated with providing services on site with and without 
patient transportation to nearby facilities.  Under the theory-based education intervention, we 
estimated the costs of providing telephone counseling to patients regarding the need for 
mammography.  Peer recruitment strategies include training peer navigators or lay health 
workers to recruit women residing in a geographically defined community for preventive 
services.  A peer navigator distributes educational materials and makes a follow-up call to ensure 
that the patient has received her mammogram.  Costs were estimated for the lay health worker 
and the church-based navigator models of peer recruitment.  Mobile mammography services 
allow for the provision of preventive services in underserved neighborhoods and reduce patient 
travel costs and time.  The costs of operating a mobile mammography van are also estimated for 
this study.  Public communications campaigns promote preventive services via radio, television, 
or printed media using free airtime or space allotted for public services announcements (PSAs) 
by the media.  These may be conducted through a clinic, a community-based organization 
(CBO), or through a local health department.  We examined the cost associated with producing 
PSAs through a health clinic or CBO.          
 
Provider-targeted intervention strategies.  Provider-targeted intervention strategies to 
increase mammography use include strategies to increase the number of times a physician makes 
an appropriate recommendation for a mammogram utilizing physician reminders and physician 
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audit with feedback systems.28-31  A physician reminder system consists of placing a note in a 
patient’s record or chart alerting the physician when a mammogram is due.  Under the physician 
audit with feedback system, a physician’s performance is evaluated and a determination is made 
as to whether mammograms were ordered on time for eligible patients.  For an institution to 
monitor a physician’s performance or to provide preventive service reminders, it must obtain and 
maintain a record indicating when the patient’s mammogram is due and whether or not the 
physician ordered it on time.  Thus, it is necessary to review all of the medical records of at risk 
patients in a physician’s patient panel and to maintain a computerized record of tests due.  To 
review a physician’s performance under the audit with feedback intervention, it is also necessary 
to hold periodic peer meetings.  Another strategy involves educating physicians regarding the 
utility of preventive services.32, 33  In this scenario, physicians undergo formal training in a group 
setting on an annual or semi-annual basis. 
 
Interventions to Improve Follow-up after an Abnormal Mammogram 
 
Patient-targeted intervention strategies.  Patient-targeted intervention strategies to 
improve follow-up after an abnormal mammogram include telephone counseling and same-day 
breast biopsy for women with positive mammograms.  Under telephone counseling, women 
receive a telephone call that may incorporate a reminder, counseling, and scheduling of an 
appointment for a mammogram.35-37, 39  Another approach to reduce a patient’s barriers to 
diagnostic services involves performing a minimally invasive breast biopsy immediately 
following a positive mammogram.  In this intervention, a radiologist refers patients in need of a 
biopsy to an on site surgeon who then counsels the patient and performs a biopsy.  In addition to 
removing a barrier to confirmatory tests, we assume that this intervention also saves time and 
transportation costs for the patient. 
 
 Cost Methods 
 
 All costs were determined using the micro-costing approach, were adjusted to 2000 
dollars, and include patient costs for time in treatment.40  Wages were determined from the 
Bureau of Labor Statistics50 and office supply costs were obtained from various commercial 
dealers.51-54  All analyses were conducted using Excel 97 SR-1 (Microsoft Corporation, 
Redmond WA).  We assumed that all providers would be physicians and that the patient volume 
would be representative of the typical outpatient department of a teaching hospital.  Finally, we 
assumed that patients would be fully compliant with each intervention, so that researchers and 
managers may more readily use these data for other purposes.   
 
 Non-medical costs included patient time spent receiving screening, diagnostic evaluation, 
and treatment, and travel and waiting time for receiving care.  Average travel and waiting times 
were based on data from the National Health Interview Survey, and time spent receiving services 
was estimated form prior research and clinical estimates.55  Costs were obtained by multiplying 
these times by median US wage rates for African-American women.  Since wages and labor 
force participation rates are lower for African-American women than for white women, we 
explored the impact of using average US wages rates in sensitivity analyses.  The costs of lost 
productivity due to breast cancer morbidity and mortality will be accounted for in the cost 
effectiveness model by decrements in utilities used to “quality-adjust” years of life saved. 
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 In addition to calculating base costs for each intervention, a sensitivity analysis was 
conducted to calculate the low and high cost estimates for each intervention for a fixed patient 
caseload.  Under each intervention, the cost components that contributed 20 percent or more to 




 Table 2 lists the per patient costs for each of the twelve intervention strategies including 
base costs and the low and high estimates from the sensitivity analysis.  First year start-up costs 
are presented in addition to ongoing annual costs.  The cost of mammography is included in the 
cost of each intervention. 
 
TABLE 2-Per Patient Costs for Each Intervention 
 
 Base Case Low Estimate High Estimate 
A.  Interventions to Increase Mammography Use    
      Patient-targeted Strategies    
      1.  Reminder Letters    
           First Year 56.58 55.79 57.38 
           Ongoing 55.40 54.62 56.18 
      2.  Same-day Screening    
           With Patient Transportation    
           First Year 49.35 47.64 51.05 
           Ongoing 49.33 47.63 51.04 
           Same-day Screening    
           Without Patient Transportation    
           First Year 48.12 46.73 49.50 
           Ongoing 48.10 46.72 49.49 
      3.  Theory-based Education    
           First Year 55.05 54.42 55.68 
           Ongoing 54.96 54.33 55.59 
      4.  Lay Health Worker Navigator    
           First Year 69.74 65.48 74.01 
           Ongoing 69.41 65.14 73.68 
      5.  Church-based Navigator    
           First Year 230.59 203.94 261.64 
           Ongoing 161.40 134.75 188.05 
      6.  Mobile Mammography Van    
           First Year 68.65 66.85 69.68 
           Ongoing 67.41 65.60 68.44 
       7.  Public Service Announcements    
           First Year 53.00 52.93 53.06 
           Ongoing 52.73 52.67 52.79 
      Provider-targeted Strategies    
      8.  Physician Reminders    
           First Year 55.48 54.99 55.96 
           Ongoing 54.27 53.79 54.76 
      9.  Physician Education    
           First Year 52.55 52.54 52.55 
           Ongoing 52.54 52.53 52.54 
      10. Audit with Feedback    
           First Year 53.88 53.81 53.89 
           Ongoing 52.68 52.64 52.72 
B.  Interventions to Improve Follow-up    
      After Abnormal Mammogram    
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      Patient-targeted Strategies    
      11. Telephone Counseling    
           First Year 58.16 56.83 59.49 
           Ongoing 56.96 55.63 58.29 
      12. Same-day Biopsy    
           First Year 47.08 46.92 49.85 
           Ongoing 47.06 46.90 49.82 
Average of all programs, first year + ongoing costs 66.17 63.15 69.51 




Same day scheduling of a mammogram with or without patient transportation, public 
service announcements, physician education, physician audit with feedback, and same day 
scheduling of a biopsy cost $47-$53 per patient per year on an ongoing basis.  This is primarily 
due to public communications campaigns reaching a large number of patients and the low-
intensity nature of the same-day scheduling and physician-targeted interventions.  Interventions 
that require full-time personnel to maintain the program, such as patient reminder letters, theory-
based education, physician reminders, and telephone counseling, are more expensive and cost 
approximately $54-$57 per patient on an ongoing basis.  The three most expensive interventions 
are the mobile mammography van, lay health workers, and church based navigators.  These 
intervention strategies are the most intensive requiring the most equipment or personnel and cost 
approximately $67-$161 per patient on an ongoing basis.  The two-year average base cost for all 




 Interventions designed to improve early stage breast cancer detection rates and follow-up 
treatment rates after an abnormal mammogram in African-American women range from $47 to 
$161 per patient on an ongoing basis.  Further cost effectiveness analyses will assess optimal  
intervention strategies that will maximize effectiveness most efficiently.  When effectiveness 
data are lacking, we will perform threshold analyses to inform us of what minimum effectiveness 
targets would make these interventions comparable to other cost effective interventions.    
 
Conclusion   
 
 The added costs of targeted cancer control programs for vulnerable African-American 
women are small and have the potential to be offset by the gains in quality-adjusted life years 
saved as a result of detection at an earlier stage of diagnosis and improved follow-up and 
treatment.  These preliminary program cost findings will be integrated into the full CEA model, 
which is currently still under development. It is hoped that once the full model is completed later 
this year, the results will be translated from research into practice, through partnerships and 
collaborations among other researchers, consumers, advocacy groups, providers, insurers and 
legislators. The challenge to reduce the disparity in breast cancer mortality rates between African 
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